PYRAZOLSULFONAMIDE ALS ANTITUMORMITTEL

Patent europeic · EP3953331 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3953331
Numer da la dumonda
EP20788312
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
06-04-2020
Publitgà
16-02-2022
Concedì
20-11-2024
Stritgà
25-11-2025
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 401/14 (2006.01)
C07D 403/12 (2006.01)
C07D 403/14 (2006.01)
C07D 405/14 (2006.01)
C07D 409/14 (2006.01)
A61K 31/416 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201962832125 P 10.04.2019
Dumonda PCT
PCT/US2020/026799 06.04.2020
Publicaziun PCT
WO2020/210139 15.10.2020
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-11-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.11.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.11.2025

  2. 24-09-2025

    Midada

    Published in Swissreg on 24.09.2025

  3. 20-11-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 20.11.2024

Partidas

Inventur

ESTRADA, Michelle Ann

Dallas, Texas 75235-7323, US

GRINA, Jonas

Dallas, Texas 75235-7323, US

WEHN, Paul

Dallas, Texas 75235-7323, US

XU, Rui

Dallas, Texas 75235-7323, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.